ID
32907
Description
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form asks for concomitant medications of the subject. It should be filled out at first visit, and re-checked at each subsequent visit.
Lien
https://clinicaltrials.gov/ct2/show/NCT00241644
Mots-clés
Versions (3)
- 01/11/2018 01/11/2018 -
- 17/11/2018 17/11/2018 -
- 19/11/2018 19/11/2018 - Sarah Riepenhausen
Détendeur de droits
GlaxoSmithKline
Téléchargé le
19 novembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Concomitant Medication
- StudyEvent: ODM
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Medication Data
Alias
- UMLS CUI-1
- C2347852
Description
Trade/Name of Medication
Type de données
text
Alias
- UMLS CUI [1]
- C2360065
Description
Medical Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Description
Prophylactic Medication
Type de données
boolean
Alias
- UMLS CUI [1]
- C0420172
Description
Total daily dose
Type de données
text
Alias
- UMLS CUI [1]
- C2348070
Description
Medication Route
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Start Date of Medication
Type de données
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0808070
Description
End Date of Medication
Type de données
date
Alias
- UMLS CUI [1,1]
- C0013227
- UMLS CUI [1,2]
- C0806020
Description
Continuing Medication
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826666
Description
Only to be filled out by GSK staff members
Type de données
text
Alias
- UMLS CUI [1,1]
- C0947611
- UMLS CUI [1,2]
- C0008961
Similar models
Concomitant Medication
- StudyEvent: ODM
C0013227 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
C0806020 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,2])